Release Date: June 30, 2025
Expiration Date: June 30, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in atopic dermatitis (AD). In this educational program, these experts focus on topical steroid withdrawal (TSW) in patients with AD. They discuss identifying TSW, diagnosing TSW challenges, and collaborating with the patient to improve outcomes.
This educational activity is an archive of the live symposium held on June 6, 2025.
Target Audience
This educational activity is directed toward HCPs involved in the management of atopic dermatitis. Specifically dermatologists, dermatology physician assistants, dermatology nurse practitioners, and primary care providers.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the signs and symptoms of topical steroid withdrawal in patients with atopic dermatitis
- Implement best-practice protocols for monitoring the long-term effects of topical corticosteroids in patients with atopic dermatitis
- Discuss management strategies for patients with suspected topical steroid withdrawal
Diego Ruiz Dasilva, MD, FAAD
Eastern Virginia Medical School
Assistant Professor
Virginia Beach, Virginia
Disclosures: Speaker/Advisor: AbbVie, Arcutis, Dermavent, Leo, Pfizer, Galderma, Sanofi, UCB
Brad Glick, DO, MPH, FAAD
Dermatologist and Dermatologic Surgeon
Glick Skin Institute
Margate, FL
Disclosures: Advisor/Investigator/Speaker: AbbVie, Arcutis Biotherapeutics, Amgen, Sun Pharma, Lilly, Dermavant Sciences, BMS, Dermira, Regeneron Investigator: AstraZeneca, Bellus/GSK, Celledex, Nimbus Lakshmi inc, Cara Therapeutics, ChemoCentryx, Brickell Biotech, CorEvitas Registry PSO , CorEvitas Registry AD, PROSE Registry for AD Investigator/Advisor: Alumis, Apogee Therapeutics, Galderma Advisor/Speaker: Novartis, Incyte, EPI/Novan, Sanofi/Genzyme, Pfizer, Ortho Dermatologics, UCB. Advisor: Leo Pharma Speaker: Janssen Stockholder: Top MD
Peter A. Lio, MD
Founding Director
Chicago Integrative Eczema Center
Chicago, IL
Disclosures: Advisory Board: Almirall, Amyris, Bristo -Meyers Squibb, Dermavent, Janssen, LEO Pharma, Micreos, Pelthos Therapeutics, Skinfix, UCB Speaker/Advisory Board: AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oreal, MyOR Diagnostics, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Verrica Advisory Board/Stock Options: Alphyn Biologics, Codex Labs, Concerto Viosci, Soteri Skin, Stratum Biosciences, Thimble Health, Verdant Scientific, Yobee Care Patent Pending: Theraplex
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource, LLC, (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here